Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer
Natural killer (NK) cell activity is influenced by a complex integration of signaling pathways activated downstream of both activating and inhibitory surface receptors. The tumor microenvironment can suppress NK cell activity, and there is a great clinical interest in understanding whether modulatin...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2018/6248590 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832554656200392704 |
---|---|
author | Bin Han Fang-yuan Mao Yong-liang Zhao Yi-pin Lv Yong-sheng Teng Mubing Duan Weisan Chen Ping Cheng Ting-ting Wang Zhong-yuan Liang Jin-yu Zhang Yu-gang Liu Gang Guo Quan-ming Zou Yuan Zhuang Liu-sheng Peng |
author_facet | Bin Han Fang-yuan Mao Yong-liang Zhao Yi-pin Lv Yong-sheng Teng Mubing Duan Weisan Chen Ping Cheng Ting-ting Wang Zhong-yuan Liang Jin-yu Zhang Yu-gang Liu Gang Guo Quan-ming Zou Yuan Zhuang Liu-sheng Peng |
author_sort | Bin Han |
collection | DOAJ |
description | Natural killer (NK) cell activity is influenced by a complex integration of signaling pathways activated downstream of both activating and inhibitory surface receptors. The tumor microenvironment can suppress NK cell activity, and there is a great clinical interest in understanding whether modulating tumor-mediated NK cell suppression and/or boosting preexisting NK cell numbers in cancer patients is therapeutically viable. To this light, we characterized the surface receptor phenotypes of peripheral blood NK cells and examined their clinical relevance to human gastric cancer (GC). We found that the proportion of peripheral blood NK cells which expressed the activating receptors NKp30, NKp46, NKG2D, and DNAM-1 was significantly decreased in GC patients compared to healthy donors, and that this decrease was positively associated with tumor progression. At the same time, plasma TGF-β1 concentrations were significantly increased in GC patients and negatively correlated with the proportion of NKp30, NKp46, NKG2D, and DNAM-1 expressing NK cells. Furthermore, TGF-β1 significantly downregulated the expression of NKp30, NKp46, NKG2D, and DNAM-1 on NK cells in vitro, and the addition of galunisertib, an inhibitor of the TGF-β receptor subunit I, reversed this downregulation. Altogether, our data suggest that the decreased expression of activating receptors NKp30, NKp46, NKG2D, and DNAM-1 on peripheral blood NK cells is positively associated with GC progression, and that TGF-β1-mediated NK cell suppression may be a therapeutically targetable characteristic of GC. |
format | Article |
id | doaj-art-b34ac744ccf8477da76410edb5c91e13 |
institution | Kabale University |
issn | 2314-8861 2314-7156 |
language | English |
publishDate | 2018-01-01 |
publisher | Wiley |
record_format | Article |
series | Journal of Immunology Research |
spelling | doaj-art-b34ac744ccf8477da76410edb5c91e132025-02-03T05:50:53ZengWileyJournal of Immunology Research2314-88612314-71562018-01-01201810.1155/2018/62485906248590Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric CancerBin Han0Fang-yuan Mao1Yong-liang Zhao2Yi-pin Lv3Yong-sheng Teng4Mubing Duan5Weisan Chen6Ping Cheng7Ting-ting Wang8Zhong-yuan Liang9Jin-yu Zhang10Yu-gang Liu11Gang Guo12Quan-ming Zou13Yuan Zhuang14Liu-sheng Peng15Department of Pharmacy, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan Province 637000, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaDepartment of General Surgery and Center of Minimal Invasive Gastrointestinal Surgery, Southwest Hospital, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaLa Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3085, AustraliaLa Trobe Institute for Molecular Science, La Trobe University, Bundoora, VIC 3085, AustraliaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNational Engineering Research Center of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing 400038, ChinaNatural killer (NK) cell activity is influenced by a complex integration of signaling pathways activated downstream of both activating and inhibitory surface receptors. The tumor microenvironment can suppress NK cell activity, and there is a great clinical interest in understanding whether modulating tumor-mediated NK cell suppression and/or boosting preexisting NK cell numbers in cancer patients is therapeutically viable. To this light, we characterized the surface receptor phenotypes of peripheral blood NK cells and examined their clinical relevance to human gastric cancer (GC). We found that the proportion of peripheral blood NK cells which expressed the activating receptors NKp30, NKp46, NKG2D, and DNAM-1 was significantly decreased in GC patients compared to healthy donors, and that this decrease was positively associated with tumor progression. At the same time, plasma TGF-β1 concentrations were significantly increased in GC patients and negatively correlated with the proportion of NKp30, NKp46, NKG2D, and DNAM-1 expressing NK cells. Furthermore, TGF-β1 significantly downregulated the expression of NKp30, NKp46, NKG2D, and DNAM-1 on NK cells in vitro, and the addition of galunisertib, an inhibitor of the TGF-β receptor subunit I, reversed this downregulation. Altogether, our data suggest that the decreased expression of activating receptors NKp30, NKp46, NKG2D, and DNAM-1 on peripheral blood NK cells is positively associated with GC progression, and that TGF-β1-mediated NK cell suppression may be a therapeutically targetable characteristic of GC.http://dx.doi.org/10.1155/2018/6248590 |
spellingShingle | Bin Han Fang-yuan Mao Yong-liang Zhao Yi-pin Lv Yong-sheng Teng Mubing Duan Weisan Chen Ping Cheng Ting-ting Wang Zhong-yuan Liang Jin-yu Zhang Yu-gang Liu Gang Guo Quan-ming Zou Yuan Zhuang Liu-sheng Peng Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer Journal of Immunology Research |
title | Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer |
title_full | Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer |
title_fullStr | Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer |
title_full_unstemmed | Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer |
title_short | Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer |
title_sort | altered nkp30 nkp46 nkg2d and dnam 1 expression on circulating nk cells is associated with tumor progression in human gastric cancer |
url | http://dx.doi.org/10.1155/2018/6248590 |
work_keys_str_mv | AT binhan alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT fangyuanmao alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT yongliangzhao alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT yipinlv alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT yongshengteng alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT mubingduan alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT weisanchen alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT pingcheng alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT tingtingwang alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT zhongyuanliang alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT jinyuzhang alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT yugangliu alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT gangguo alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT quanmingzou alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT yuanzhuang alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer AT liushengpeng alterednkp30nkp46nkg2danddnam1expressiononcirculatingnkcellsisassociatedwithtumorprogressioninhumangastriccancer |